RNA Polymerase Transcription Past DNA Adducts

RNA 聚合酶转录 DNA 加合物

基本信息

  • 批准号:
    8369308
  • 负责人:
  • 金额:
    $ 29.48万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2000
  • 资助国家:
    美国
  • 起止时间:
    2000-09-30 至 2014-10-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The long range goal of this research is to gain a detailed understanding of how covalently modified bases in DNA affect RNA polymerase behavior during transcription, and to assess the subsequent cellular responses at the level of DNA repair and transcript integrity. RNA polymerases act as sensors of DNA damage when they stall at lesions in the genome, sometimes triggering damage clearance via transcription-coupled DNA repair, which overlaps with nucleotide excision repair and requires at least two additional proteins that are defective in the disease Cockayne syndrome. But the overlap of TCR with other DNA repair pathways such as base excision repair has not been unequivocally demonstrated or disproved. In contrast to DNA damage that stalls transcription complex progression, some lesions in DNA permit partial or complete transcriptional bypass, resulting in the production of full-length RNA that can contain base misinsertions or deletions, potentially compromising the nascent transcript's function via "transcriptional mutagenesis." Such changes to mRNA can result in altered proteins that affect cell physiology in fundamental ways, possibly triggering disease. Hence, the health-related problems associated with compromised transcription past DNA damage in expressed genes are potentially severe, and yet our basic understanding in this area in human cells is quite limited. In this application we propose experiments to examine the effect of DNA damage on transcription and to decipher further the mechanism of transcription coupled DNA repair. This work will be done in human cells, taking the work beyond the biochemical approaches used thus far. There are three specific aims to address these goals. We will: (1) investigate RNA polymerase II transcription past select DNA adducts; (2) determine the base sequence of the mRNA produced via bypass of each lesion; and (3) examine DNA repair, including TCR, in the site-specifically modified vector. Computer-modeling studies will play role in the continued interpretation of our results by providing molecular models of RNA polymerase II when it encounters a DNA adduct. This research shifts the long-standing emphasis from the effects of DNA lesions on DNA replication, which is important in cells undergoing growth and division, to the role DNA damage plays in RNA synthesis, a process that occurs in all cells, including those that are undergoing division or are terminally differentiated. This research will increase our understanding of the deleterious effect that environmental genotoxic agents have on transcription in humans. While such agents are often associated with mutations and cancer, they may well pose threats to non-dividing cells and disturb RNA synthesis during growth and development, adding to their impact on human health.
描述(申请人提供):这项研究的长期目标是详细了解DNA中共价修饰的碱基在转录过程中如何影响RNA聚合酶的行为,并在DNA修复和转录本完整性的水平上评估随后的细胞反应。当RNA聚合酶在基因组中的损伤处失速时,它们充当DNA损伤的传感器,有时通过转录耦合DNA修复触发损伤清除,这与核苷酸切除修复重叠,需要至少两种在Cockayne综合征中有缺陷的额外蛋白质。但TCR与其他DNA修复途径如碱基切除修复的重叠还没有得到明确的证明或否定。与阻碍转录复合体进展的DNA损伤相反,DNA中的一些损伤允许部分或完全转录旁路,导致产生全长RNA,其中可能包含碱基错误插入或缺失,从而可能通过“转录突变”损害新生转录本的功能。这种对mRNA的改变可能导致蛋白质的改变,从根本上影响细胞生理,可能引发疾病。因此,与表达基因中DNA损伤的转录受损相关的健康相关问题是潜在的严重的,然而我们对人类细胞这一领域的基本理解是相当有限的。在这一应用中,我们建议进行实验,以检测DNA损伤对转录的影响,并进一步破译转录偶联DNA修复的机制。这项工作将在人类细胞中完成,使这项工作超越了迄今使用的生化方法。实现这些目标有三个具体目标。我们将:(1)通过选择DNA加合物来研究RNA聚合酶II的转录;(2)确定通过绕过每个病变产生的mRNA的碱基序列;以及(3)检查DNA修复,包括在定点修饰的载体中的TCR。计算机模拟研究将通过提供RNA聚合酶II遇到DNA加合物时的分子模型,在继续解释我们的结果方面发挥作用。这项研究将长期以来的重点从DNA损伤对DNA复制的影响转移到DNA损伤在RNA合成中的作用,RNA合成是一个发生在所有细胞中的过程,包括那些正在进行分裂或末端分化的细胞。这项研究将增加我们对环境遗传毒性物质对人类转录的有害影响的理解。虽然这类药物经常与突变和癌症有关,但它们很可能对未分裂的细胞构成威胁,并扰乱生长和发育过程中的RNA合成,增加对人类健康的影响。

项目成果

期刊论文数量(8)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Increased flexibility enhances misincorporation: temperature effects on nucleotide incorporation opposite a bulky carcinogen-DNA adduct by a Y-family DNA polymerase.
灵活性的增加会加剧错误掺入:温度对核苷酸掺入的影响与 Y 家族 DNA 聚合酶产生的大体积致癌物-DNA 加合物相反。
  • DOI:
    10.1074/jbc.m606769200
  • 发表时间:
    2007
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Perlow-Poehnelt,RebeccaA;Likhterov,Ilya;Wang,Lihua;Scicchitano,DavidA;Geacintov,NicholasE;Broyde,Suse
  • 通讯作者:
    Broyde,Suse
Transcription and DNA adducts: what happens when the message gets cut off?
  • DOI:
    10.1016/j.dnarep.2004.06.004
  • 发表时间:
    2004-12
  • 期刊:
  • 影响因子:
    3.8
  • 作者:
    D. Scicchitano;E. Olesnicky;A. Dimitri
  • 通讯作者:
    D. Scicchitano;E. Olesnicky;A. Dimitri
Transcription past DNA adducts derived from polycyclic aromatic hydrocarbons.
转录后的 DNA 加合物源自多环芳烃。
  • DOI:
    10.1016/j.mrfmmm.2005.03.015
  • 发表时间:
    2005
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Scicchitano,DavidA
  • 通讯作者:
    Scicchitano,DavidA
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

David A Scicchitano其他文献

David A Scicchitano的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('David A Scicchitano', 18)}}的其他基金

RNA Polymerase Transcription Past DNA Adducts
RNA 聚合酶转录 DNA 加合物
  • 批准号:
    6778625
  • 财政年份:
    2000
  • 资助金额:
    $ 29.48万
  • 项目类别:
HUMAN RNA POLYMERASE II TRANSCRIPTION PAST PAH ADDUCTS
人类 RNA 聚合酶 II 转录 PAH 加合物
  • 批准号:
    6525247
  • 财政年份:
    2000
  • 资助金额:
    $ 29.48万
  • 项目类别:
RNA Polymerase Transcription Past DNA Adducts
RNA 聚合酶转录 DNA 加合物
  • 批准号:
    7082047
  • 财政年份:
    2000
  • 资助金额:
    $ 29.48万
  • 项目类别:
RNA Polymerase Transcription Past DNA Adducts
RNA 聚合酶转录 DNA 加合物
  • 批准号:
    7470187
  • 财政年份:
    2000
  • 资助金额:
    $ 29.48万
  • 项目类别:
RNA Polymerase Transcription Past DNA Adducts
RNA 聚合酶转录 DNA 加合物
  • 批准号:
    8002023
  • 财政年份:
    2000
  • 资助金额:
    $ 29.48万
  • 项目类别:
RNA Polymerase Transcription Past DNA Adducts
RNA 聚合酶转录 DNA 加合物
  • 批准号:
    7254181
  • 财政年份:
    2000
  • 资助金额:
    $ 29.48万
  • 项目类别:
HUMAN RNA POLYMERASE II TRANSCRIPTION PAST PAH ADDUCTS
人类 RNA 聚合酶 II 转录 PAH 加合物
  • 批准号:
    6167227
  • 财政年份:
    2000
  • 资助金额:
    $ 29.48万
  • 项目类别:
HUMAN RNA POLYMERASE II TRANSCRIPTION PAST PAH ADDUCTS
人类 RNA 聚合酶 II 转录 PAH 加合物
  • 批准号:
    6382376
  • 财政年份:
    2000
  • 资助金额:
    $ 29.48万
  • 项目类别:
RNA Polymerase Transcription Past DNA Adducts
RNA 聚合酶转录 DNA 加合物
  • 批准号:
    6916582
  • 财政年份:
    2000
  • 资助金额:
    $ 29.48万
  • 项目类别:
RNA Polymerase Transcription Past DNA Adducts
RNA 聚合酶转录 DNA 加合物
  • 批准号:
    7784041
  • 财政年份:
    2000
  • 资助金额:
    $ 29.48万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 29.48万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 29.48万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 29.48万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 29.48万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 29.48万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 29.48万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 29.48万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 29.48万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 29.48万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 29.48万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了